Andrew is a Professor of Human Psychopharmacology and Vice Chancellor Fellow in the Department of Psychology. He rejoined Northumbria University in 2025 following seventeen years in Melbourne, Australia where he was director of the Centre for Human Psychopharmacology at Swinburne University. Following a degree in Psychology from Plymouth University, Andrew completed his PhD and a postdoc at the Brain and Behaviour Research Centre, Open University before joining Northumbria University. He established the Human Cognitive Neuroscience Unit at Northumbria (now the Brain Performance and Nutrition Research Centre). Andrew holds Adjunct Research Professor positions at Monash and Swinburne Universities in Australia.

Andrew has been awarded over 12 million pounds in government and industry research funding. He has authored more than 300 peer-reviewed journal articles and over 20 book chapters and books. He is placed in the top 2% of scientists globally based on citations and academic impact (Stanford/Elsevier Scientist Rankings).

Andrew acted as advisor to the UK Parliamentary Forum on Diet and Health, and to the Canadian Ministry of Health. He was a member of Australia's inaugural Health and Medical Research Council Engagement and Impact panel (Health and Life Sciences) and, until 2025, the Australian Research Council Medical Research Advisory Group. He has several editoral roles including as Speciality Chief Editor for Frontiers in Psychology, Nutrition and Brain Health. 

Andrew has acted as an expert advisor to numerous UK, European, North American and Asia-Pacific industry partners, ranging from start-ups to global Fortune 500 companies. This work aims to translate research findings into evidence-based benefits for brain and mental health.

Andrew is interested various aspects of Human Psychopharmacology including:

• Brain and behavioural effects of ‘nutra’ interventions (nutrition, nutrients, nutraceuticals, nootropics and whole dietary patterns).
• Functional effects of alcohol hangover.
• Understanding the mechanisms underlying acute and chronic cognitive enhancement and imapirment using neuroimaging and biomarker measurement.
• Development and application of evidence-based interventions to optimise cognitive performance and mental health, and reduce the risk of cognitive decline and dementia (including with industry partners).